Stockscreener 앱 받기
4.06
4.64%
0.18
전일 마감가:
$3.88
열려 있는:
$3.95
하루 거래량:
168.42K
Relative Volume:
2.68
시가총액:
$346.17M
수익:
-
순이익/손실:
$-29.64M
주가수익비율:
-9.4419
EPS:
-0.43
순현금흐름:
$-39.43M
1주 성능:
+8.56%
1개월 성능:
+4.91%
6개월 성능:
+38.10%
1년 성능:
+35.33%
1일 변동 폭
$3.90
$4.28
1주일 범위
$3.67
$4.28
52주 변동 폭
$2.30
$4.69
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
DRTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
4.06 | 330.82M | 0 | -29.64M | -39.43M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-15 | 개시 | Citigroup | Buy |
| 2023-04-24 | 개시 | H.C. Wainwright | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-08 | 개시 | Piper Sandler | Overweight |
| 2022-04-04 | 개시 | Citigroup | Buy |
Alpha Tau Medical Ltd 주식(DRTS)의 최신 뉴스
Why Alpha Tau Medical Ltd. Equity Warrant stock is popular among millennialsMarket Risk Analysis & Low Risk Investment Opportunities - Newser
Will Alpha Tau Medical Ltd. stock rally after Fed decisionsJuly 2025 Outlook & Stock Portfolio Risk Management - Newser
Alpha Tau announces two Alpha DaRT abstracts at ASCO Symposium - TipRanks
Alpha Tau Medical to Present Pancreatic Cancer Research at 2026 ASCO Symposium - TipRanks
Alpha Tau Announces Presentation of Two Alpha DaRT - GlobeNewswire
Is Alpha Tau Medical Ltd. Equity Warrant stock a smart buy before Fed meetingJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - Newser
How Alpha Tau Medical Ltd. stock benefits from global expansionMarket Sentiment Summary & Risk Adjusted Buy/Sell Alerts - Newser
Alpha Tau Medical Ltd. Receives FDA Approval to Initiate A Trial for Patients with Locally Recurrent Prostate Cancer - marketscreener.com
Alpha Tau receives FDA approval to initiate a trial for patients with locally recurrent prostate cancer - marketscreener.com
Alpha Tau Medical Receives FDA Approval for Prostate Cancer Trial - TipRanks
Alpha Tau receives FDA approved IDE application to initiate study of Alpha DaRT - TipRanks
Alpha Tau (NASDAQ: DRTS) gains FDA IDE to test Alpha DaRT in recurrent prostate cancer - Stock Titan
Alpha Tau to Participate in December Investor Conferences - The Manila Times
What insider trading reveals about Alpha Tau Medical Ltd. stockJuly 2025 Momentum & Safe Capital Growth Stock Tips - moha.gov.vn
What is HC Wainwright’s Forecast for DRTS FY2025 Earnings? - Defense World
Alpha Tau Medical (NASDAQ:DRTS) Receives Buy Rating from HC Wainwright - Defense World
Promising Developments and Strategic Trials Support Buy Rating for Alpha Tau Medical Ltd. - TipRanks
HC Wainwright & Co. Reiterates Alpha Tau Medical (DRTS) Buy Recommendation - MSN
Alpha Tau Medical Reports Q3 2025 Progress and Financials - MSN
Alpha Tau reports Q3 EPS (32c), consensus (12c) - MSN
Alpha Tau Eyes Year-End Japanese Clearance For Alpha DaRT Treatment In Recurrent Head & Neck Cancer - Nasdaq
Alpha Tau Medical Reports Q3 2025 Results and Advances in Cancer Therapy - TipRanks
[6-K] Alpha Tau Medical Ltd. Current Report (Foreign Issuer) | DRTS SEC FilingForm 6-K - Stock Titan
Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
How sustainable is Alpha Tau Medical Ltd. Equity Warrant stock dividend payoutMarket Sentiment Report & Technical Analysis for Trade Confirmation - newser.com
How Alpha Tau Medical Ltd. Equity Warrant stock performs in high volatility marketsJobs Report & Daily Entry Point Trade Alerts - newser.com
How Alpha Tau Medical Ltd. Equity Warrant stock responds to policy changesMarket Performance Summary & Capital Protection Trading Alerts - newser.com
Is Alpha Tau Medical Ltd. stock a defensive play in 2025Trade Analysis Report & Risk Controlled Daily Trade Plans - newser.com
Applying Elliott Wave Theory to Alpha Tau Medical Ltd. Equity WarrantJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com
Relative strength of Alpha Tau Medical Ltd. in sector analysis2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Published on: 2025-11-19 15:11:14 - newser.com
How Alpha Tau Medical Ltd. Equity Warrant stock performs in rising dollar environmentShare Buyback & Scalable Portfolio Growth Ideas - newser.com
Heatmap analysis for Alpha Tau Medical Ltd. Equity Warrant and competitorsJuly 2025 Institutional & Weekly Top Performers Watchlists - newser.com
Will Alpha Tau Medical Ltd. Equity Warrant stock benefit from sector rotation2025 Key Highlights & Smart Money Movement Alerts - newser.com
Published on: 2025-11-19 05:24:32 - newser.com
Alpha Tau Medical Ltd. Equity Warrant stock prediction for this weekIndex Update & Reliable Price Breakout Alerts - newser.com
How to forecast Alpha Tau Medical Ltd. Equity Warrant trends using time series - newser.com
Published on: 2025-11-19 00:19:53 - newser.com
Is Alpha Tau Medical Ltd. stock undervalued vs historical averagesM&A Rumor & Verified Swing Trading Watchlists - newser.com
Published on: 2025-11-18 18:09:39 - newser.com
Will Alpha Tau Medical Ltd. outperform the marketWeekly Trade Recap & Intraday High Probability Alerts - newser.com
Bassett Among First to Participate in Pancreatic Cancer Clinical Trial - WIBX 950
Using data models to predict Alpha Tau Medical Ltd. Equity Warrant stock movementWeekly Trade Review & Safe Entry Trade Signal Reports - newser.com
Alpha Tau Medical Ltd (DRTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):